Thrombosis

News Thrombosis

• Anemia drugs does not improve health of anemic heart failure patients

  Researchers from Sahlgrenska Academy, University of Gothenburg, have found that a commonly used drug to treat anemia in heart failure patients does not improve patients’ health, nor does it reduce their risk of death from heart failure. Results of the international study were published by The New En more

• Persistence pays off in solving hemophilia mystery, showing curiosity drives discovery

  An Australian researcher has found the third and final missing piece in the genetic puzzle of an unusual form of hemophilia, more than 20 year after he discovered the first two pieces. Professor Merlin Crossley, of the University of New South Wales, and his international team studied the blood-clott more

• Greater Accuracy in Gauging Blood Coagulation

  Thrombin plays a key role in various pathologies of the haemostatic system. Overexpression of thrombin can result in thrombosis, whereas its underexpression might lead to haemophilia. Therefore, accurate monitoring of thrombin activity is crucial for determining the proper treatment of a given patie more

White papers Thrombosis

• Miniaturised Platelet Aggregation Assays using the NOVOstar Microplate Reader
  

  Platelet aggregation is a “gold standard” assay of platelet function in the research and clinical laboratory settings which is conventionally measured with aggregometers requiring large volumes of platelet suspensions and only in low throughput format. With the NOVOstar microplate reader from BMG LABTECH we present an alternative optical method to measure platelet aggregation using small volumes in 96-well format more

Publications Thrombosis

• Application of a rotating bioreactor consisting of low‐cost and ready‐to‐use medical disposables for in vitro evaluation of the endothelialization efficiency of small‐caliber v ...

  Abstract The incomplete endothelialization of especially small‐caliber vascular prostheses after implantation in patients is a major disadvantage in cardiovascular interventions. The lack of an endothelium leads to the occurrence of thrombosis at the luminal surface of artificial vascular prosth more

• Pharmacotherapy for the reduction of stent thrombosis

  The benefits of percutaneous coronary intervention (PCI) can be offset by periprocedural complications such as acute vessel closure and stent thrombosis in the absence of adequate antiplatelet and antithrombotic therapy. Additionally, conditions occurring after 30 days post-PCI, such as in-stent res more

• Newly available and recent advances in drug-eluting stents

  The introduction of drug-eluting stents has revolutionized the treatment of coronary artery disease. First-generation stents, however, were associated with relatively high revascularization rates and the risk of stent thrombosis. This has led to a worldwide search for improvements in stent technolog more

Market studies Thrombosis

• Erythropoietin (EPO) Market Report: 2012 Edition

  With the advent of novel technology, companies operating in the healthcare/science/pharmaceutical/therapeutic area are now scaling new heights. Also this industry is boosted by the rising number of incidences of health related issues emanating from the changing lifestyle and rapidly evolving surroun more

• Estonia Pharmaceuticals and Healthcare Report Q3 2012

  BMI View: Estonia’s small pharmaceutical market is seen as having limited longer-term potential for multinationals. While the Estonian pharmaceutical market performed strongly in Q211 and Q311, weaker growth in Q411 has led to a moderate downward revision to our 2012 outlook, as our optimism that el more

• Thrombosis – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Thrombosis - Pipeline Review, H1 2012', provides an overview of the Thrombosis therapeutic pipeline. This report provides information on the therapeutic development for Thrombosis, complete with latest updates, and special features on late-stage and discontin more

Websites Thrombosis